Leader of Northamptonshire's mental health service, which was rated 'requires ... Angela Hillery, from NHS Northamptonshire Healthcare, has been shortlisted for the title of Health Service Journal's CEO of the Year after staff feedback that inspectors received in February. The report, published three weeks ago, rated the the trust ... and more » |
Friday, 18 September 2015
Leader of Northamptonshire's mental health service, which was rated 'requires ... - Northampton Chronicle & Echo
Leader of Northamptonshire's mental health service, which was rated 'requires ... - Northampton Chronicle & Echo
Scientists apply to modify embryos
Scientists apply to modify embryos
UK researchers want to use a controversial new genetic technique to carry out research into infertility. BBC News
UK researchers want to use a controversial new genetic technique to carry out research into infertility. BBC News
Lives being put at risk - NHS report
Lives being put at risk - NHS report
Differences in access to key NHS services, including stroke and cancer care, is putting patients at risk, an official report suggests. BBC News
Differences in access to key NHS services, including stroke and cancer care, is putting patients at risk, an official report suggests. BBC News
Antidepressant paroxetine study 'under-reported data on harms'
Antidepressant paroxetine study 'under-reported data on harms'
"Seroxat [paroxetine] study under-reported harmful effects on young people, say scientists," The Guardian reports. Researchers have reanalysed data about the antidepressant paroxetine – no longer prescribed to young people – and claim important details were not made public.
Researchers who looked at data from the now infamous 1990s "study 329" trial of the antidepressant paroxetine, found reports of suicide attempts that were not included in the original research paper.
The makers of paroxetine, GlaxoSmithKline (GSK), marketed paroxetine as a safe and effective antidepressant for children, despite the evidence of harms. The US Department of Justice sued GSK for a record $3 billion for making false claims.
The new analysis of thousands of pages of data contradicted the original claims that paroxetine was "generally well-tolerated and effective" for treating adolescents with depression. By contrast, the new analysis found "no advantage" from paroxetine and an "increase in harms", compared to placebo.
This new analysis found that the original study paper over-reported the effectiveness of paroxetine and under-estimated potential harms. It raises questions about how much we can rely on the reported results of medical trials, without independent access to review the raw trial data.
"Seroxat [paroxetine] study under-reported harmful effects on young people, say scientists," The Guardian reports. Researchers have reanalysed data about the antidepressant paroxetine – no longer prescribed to young people – and claim important details were not made public.
Researchers who looked at data from the now infamous 1990s "study 329" trial of the antidepressant paroxetine, found reports of suicide attempts that were not included in the original research paper.
The makers of paroxetine, GlaxoSmithKline (GSK), marketed paroxetine as a safe and effective antidepressant for children, despite the evidence of harms. The US Department of Justice sued GSK for a record $3 billion for making false claims.
The new analysis of thousands of pages of data contradicted the original claims that paroxetine was "generally well-tolerated and effective" for treating adolescents with depression. By contrast, the new analysis found "no advantage" from paroxetine and an "increase in harms", compared to placebo.
This new analysis found that the original study paper over-reported the effectiveness of paroxetine and under-estimated potential harms. It raises questions about how much we can rely on the reported results of medical trials, without independent access to review the raw trial data.
Creating healthy workplaces: A toolkit for the NHS
Creating healthy workplaces: A toolkit for the NHS
This new toolkit aims to support NHS organisations to improve the staff health, wellbeing, effectiveness and productivity by providing practical, step-by-step information on how to implement the six pieces of workplace guidance from the National Institute for Health and Clinical Excellence (NICE). Latest Employer News
This new toolkit aims to support NHS organisations to improve the staff health, wellbeing, effectiveness and productivity by providing practical, step-by-step information on how to implement the six pieces of workplace guidance from the National Institute for Health and Clinical Excellence (NICE). Latest Employer News
Open consultation: The role of the National Data Guardian for health and social care
Open consultation: The role of the National Data Guardian for health and social care
This consultation seeks views on the responsibilities of the statutory National Data Guardian for health and social care. The responses will form a major part of the development for more detailed proposals to establish the National Data Guardian for health and social care on a statutory footing.
The National Data Guardian for health and social care will help to ensure that personal confidential data is held and used to support better outcomes from health and care services, at the same time providing confidence that there are thorough safeguards in place to protect personal confidential data. Department of Health
This consultation seeks views on the responsibilities of the statutory National Data Guardian for health and social care. The responses will form a major part of the development for more detailed proposals to establish the National Data Guardian for health and social care on a statutory footing.
The National Data Guardian for health and social care will help to ensure that personal confidential data is held and used to support better outcomes from health and care services, at the same time providing confidence that there are thorough safeguards in place to protect personal confidential data. Department of Health
Guidance: FGM enhanced dataset: guidance on NHS staff responsibilities
Guidance: FGM enhanced dataset: guidance on NHS staff responsibilities
This document provides support and guidance to NHS organisations to know how they can meet the requirements to collect and submit data about patients with FGM. This guidance relates to the Female Genital Mutilation (FGM) Enhanced Dataset by the Health and Social Care Information Centre and the forthcoming professional duty about FGM to be published October 2015.
This includes an explanation of the legal basis for the collection of the information. It describes what and how NHS organisations need to communicate with patients about this work. The document also explains additional work underway to support GP practices with this work. Department of Health
This document provides support and guidance to NHS organisations to know how they can meet the requirements to collect and submit data about patients with FGM. This guidance relates to the Female Genital Mutilation (FGM) Enhanced Dataset by the Health and Social Care Information Centre and the forthcoming professional duty about FGM to be published October 2015.
This includes an explanation of the legal basis for the collection of the information. It describes what and how NHS organisations need to communicate with patients about this work. The document also explains additional work underway to support GP practices with this work. Department of Health
Passive smokers have 20% higher risk of diabetes, new study finds
Passive smokers have 20% higher risk of diabetes, new study finds
Someone exposed to second-hand smoke has a 20 per cent higher chance of becoming a diabetic, according to a new study. Independent
Someone exposed to second-hand smoke has a 20 per cent higher chance of becoming a diabetic, according to a new study. Independent
GP funding per patient varies two-fold between CCGs, official data show
GP funding per patient varies two-fold between CCGs, official data show
GP practices in some CCGs receive twice as much per weighted patient as their counterparts in other areas, official data on payments to general practice reveal. GP Online
GP practices in some CCGs receive twice as much per weighted patient as their counterparts in other areas, official data on payments to general practice reveal. GP Online
'Super-gonorrhoea' outbreak across north of England sparks national alert
'Super-gonorrhoea' outbreak across north of England sparks national alert
Public Health England 'concerned' about drug-resistant strain first reported in Leeds but which has spread to Macclesfield, Oldham and Scunthorpe. Telegraph
Public Health England 'concerned' about drug-resistant strain first reported in Leeds but which has spread to Macclesfield, Oldham and Scunthorpe. Telegraph
Subscribe to:
Posts (Atom)